Mermis Joel D, Strom Jeremy C, Greenwood John P, Low Derek M, He Jianghua, Stites Steven W, Simpson Steven Q
1 Department of Medicine, Division of Pulmonary and Critical Care Medicine.
Ann Am Thorac Soc. 2014 Nov;11(9):1404-10. doi: 10.1513/AnnalsATS.201404-175OC.
Peripherally inserted central catheters (PICCs) are common in the treatment of patients with cystic fibrosis (CF). Previous reports suggest that patients with CF are at increased risk for PICC-associated deep vein thrombosis (DVT).
We assessed potential risk factors for symptomatic PICC-associated DVT with subsequent implementation of a quality improvement (QI) initiative to reduce PICC-associated DVT in patients with CF.
This was a 5-year retrospective cohort study with subsequent 21-month prospective observation following implementation of a QI intervention in adults (aged 18 yr or older) with CF. All patients with a PICC inserted from July 2006 to March 2013 at our CF Foundation-accredited center were included. Symptomatic DVT was diagnosed by Doppler ultrasound. PICC insertions were analyzed, and nine risk factors for DVT were analyzed to formulate a QI initiative to reduce risk of PICC-associated DVT. The QI program focused on staff education and included modification to PICC order entry with a 4 French (F) single-lumen (SL) catheter as standard for all patients with CF.
A total of 369 PICCs were analyzed in 117 unique patients for a total of 5,437 PICC-days of placement. Symptomatic DVT was diagnosed in 28 (7.6%) of the 369 PICCs analyzed. Using regression analysis, the strongest predictors for DVT occurrence were warfarin use (odds ratio [OR] = 9.2, P = 0.006) and history of PICC-associated DVT (OR = 2.97, P = 0.08). Insertion of a 4F SL PICC resulted in zero symptomatic DVT. Zero episodes of DVT associated with 4F PICC insertion prevented use of PICC size in regression analysis. However, univariate analysis revealed that insertion of a 4F SL PICC instead of either 5F double lumen or 6F triple lumen was associated with a reduction in PICC-associated DVT (P = 0.001). After the QI intervention, 4F SL catheter insertion substantially increased to 65.8% of all PICCs inserted, whereas 6F triple-lumen catheter insertion declined to 6.8% of PICCs inserted. The QI initiative resulted in an absolute risk reduction in DVT per PICC placed of 6.1% (P = 0.055).
To reduce risk of PICC-associated DVT in patients with CF, QI strategies should focus on insertion of smaller-diameter 4F PICCs and reduction in PICC use in high-risk patients when possible.
经外周静脉穿刺中心静脉导管(PICC)在囊性纤维化(CF)患者的治疗中很常见。既往报道提示,CF患者发生PICC相关深静脉血栓形成(DVT)的风险增加。
我们评估了有症状的PICC相关DVT的潜在危险因素,随后实施了一项质量改进(QI)措施,以降低CF患者中PICC相关DVT的发生率。
这是一项为期5年的回顾性队列研究,在对成年(年龄≥18岁)CF患者实施QI干预后,进行了为期21个月的前瞻性观察。纳入了2006年7月至2013年3月在我们CF基金会认证中心置入PICC的所有患者。通过多普勒超声诊断有症状的DVT。分析PICC置入情况,并对9个DVT危险因素进行分析,以制定一项QI措施,降低PICC相关DVT的风险。QI项目侧重于工作人员培训,包括修改PICC医嘱录入,将4法国规格(F)的单腔(SL)导管作为所有CF患者的标准导管。
共分析了117例独特患者的369根PICC,累计置管天数为5437天。在分析的369根PICC中,有28根(7.6%)诊断为有症状的DVT。通过回归分析,DVT发生的最强预测因素是使用华法林(比值比[OR]=9.2,P=0.006)和有PICC相关DVT病史(OR=2.97,P=0.08)。置入4F SL PICC的患者无有症状的DVT发生。4F PICC置入未发生DVT事件,因此在回归分析中未纳入PICC规格因素。然而,单因素分析显示,与置入5F双腔或6F三腔导管相比,置入4F SL PICC可降低PICC相关DVT的发生率(P=0.001)。QI干预后,4F SL导管置入率大幅增至所有置入PICC的65.8%,而6F三腔导管置入率降至置入PICC的6.8%。QI措施使每根PICC置入相关DVT的绝对风险降低了6.1%(P=0.055)。
为降低CF患者PICC相关DVT的风险,QI策略应侧重于置入较小直径的4F PICC,并尽可能减少高危患者PICC的使用。